Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker

1 Jul 2018

Abstract excerpt

Experimental and clinical data indicate that the initiation and progress of atherosclerosis and its clinical manifestations are first caused by circulating apoB-100 lipoproteins that enter and are retained in the arterial intima. Extracellular sulfated proteoglycans (PGs) of the intima are the retention agents. The PGs also initiate physical and biochemical lipoprotein degradation with the production of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis and Cardiovascular Diseases
Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29966388
DOI: 10.3390/jcdd5030036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease BiomarkerPMID 29966388Read ↗

Atherothrombogenicity of lipoprotein(a): the debate.Semantic proximity Read ↗

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.Semantic proximity Read ↗

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular diseaseSemantic proximity Read ↗

Lipoprotein(a) and AtherosclerosisSemantic proximity Read ↗

Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions.Semantic proximity Read ↗

The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart StudySemantic proximity Read ↗

Lipoprotein(a) and calcific aortic valve disease: current evidence and future directionsSemantic proximity Read ↗

Remnant lipoproteins and atherosclerotic cardiovascular diseaseSemantic proximity Read ↗

The extracellular matrix and atherosclerosis.Semantic proximity Read ↗

Atherosclerosis and proteinase activation.Semantic proximity Read ↗

Lipoprotein(a): new insights into an atherogenic lipoprotein.Semantic proximity Read ↗

Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.